Objectives-The purposes of this study were to characterize the direct effect of the C-terminal fragment of fibrinogen ␥ chain (␥C) on microvascular endothelial permeability and to examine its molecular mechanism of action. Methods and Results-Intravital microscopy was performed to measure albumin extravasation in intact mesenteric microvasculature, followed by quantification of hydraulic conductivity in single perfused microvessels. 
F
ibrinogen comprises double polypeptides termed ␣, ␤, and ␥ chains, which form an elongated structure with two outer globular D domains connected to central E domains through coiled-coil segments. [1] [2] [3] As essential steps of the coagulation cascade, thrombin cleavage of fibrinogen and conversion to cross-linked fibrin occur in response to activation of intrinsic or extrinsic factors, followed by fibrinolysis that generates fibrin degradation products (FDPs; supplemental Figure I , available online at http://atvb.ahajournals.org). Typical FDPs include D-dimer fragments and soluble monomers containing the C termini of fibrinogen-␣, ␤ and ␥ chains, clinically measured as markers of coagulation disorder. 4 -7 The fibrinolysis cascade exerts physiological functions and pathogenic impact well beyond its role in hemostasis. Increased plasma levels of fibrinogen have been correlated with atherosclerosis, stroke, myocardium infarction, and peripheral vascular disease. 5, 6 Some fibrinogen proteolytic products have been shown to participate in cell proliferation, migration, and adhesion. 6 -8 An effect on endothelial barrier properties has been documented 9 -12 ; however, consensus has not been reached as to whether or not fibrinogen as intact protein increases vascular permeability, and even less is known regarding the receptor mechanism and signal transduction that mediates the endothelial response to specific subunits or degradation products, which are known to act distinctively based on their unique chemical structures and molecular conformations. 1, 3, 8 Investigation is often confounded by the multi-domain structure of fibrinogen and its diverse cellular targets ranging from platelets and leukocytes to endothelial cells. 7 Among various fibrinogen subunits, the C terminus of ␥ chain (␥C) is of particular importance, as it contains reactive regions that mediate fibrin cross-linking, clot formation, and interactions with other molecules. [13] [14] [15] While this domain encompasses a major component of the D fragments seen in the circulation of hypercoagulatory subjects, 13,14 intravascular coagulation is not the only source of production. During severe trauma, burn, and myocardial infarction, low-molecular-weight FDPs are produced from extravascular matrix or injured tissues, where upregulated or activated metalloproteinases, proteases, and leukocyte-derived elastases promote fibrinogen degradation. 8, 16, 17 The abundance of these proteolytic products in the vascular wall and extracellular matrix under various injurious conditions supports their potential involvement in the pathogenesis of vascular inflammation.
In an initial effort to develop therapeutic agents for pathological angiogenesis, we have cloned and purified recombinant human fibrinogen-related proteins and characterized their biochemical properties. 18, 19 The studies have led to the identification of a novel function of fibrinogen-␥ to induce apoptosis and suppress capillary tube formation through interacting with endothelial cells via a sequence exposed in its C terminus, whereas intact fibrinogen fails to effect. 18 The lack of reactivity may result from cryptic endothelial binding sites in the native form, consistent with crystallographic evidence of a dipole structure containing pocketed binding motifs. 15 We postulate that the molecular conformations of fibrinogen degradation products are critical in determining their cellular targets and biological functions, and that truncated peptides or fragments with exposed endothelial-reactive regions may be more potent than the intact protein in altering vascular function. The current study extends these original observations to a further characterization of the specific C-terminal product ␥C151-411, focusing on its endothelial effect and mechanism of action in regulating barrier properties. The data provide complementary in vivo and in vitro evidence for a direct effect of this molecule on microvascular permeability, along with insights into the receptor mechanism and signal transduction that mediates the endothelial response to ␥C.
Materials and Methods
For details, please see the supplemental materials. The ␥C fragment (residue 151 to 411, 30 kDa) was produced by cloning its cDNA into the pET21a vector and overexpressed in E. coli. The recombinant protein was renatured through urea step gradient followed by dialysis in refolding buffer with a final product resuspended in endotoxinfree PBS. Similar procedures were applied to express and purify other products, including GFP-␥C, truncated ␥C with the C-terminal dodecapeptides deleted, and the C termini of ␣ E and ␤ chains. Sprague-Dawley rats and C57BL6 mice (wild-type and integrin ␤3 Ϫ/Ϫ ) were used according to the IACUC-approved protocols. Intravital microscopy was performed to examine the mesenteric microcirculation. For measuring protein extravasation, fluorescently labeled albumin was injected and changes in the intraluminal versus extraluminal fluorescence intensity over time were recorded. 20, 21 Hydraulic conductivity (Lp) was determined using a modified Landis micro-occlusion technique that measures fluid filtration across unit areas of the capillary wall under controlled perfusion pressures. 21 Transcellular electric resistance (TER) was measured in rat lung microvascular endothelial monolayers using electric cell-substrate impedance sensor (ECIS). Additionally, Rho-GTPase activity was examined using pull-down assays, 22 and protein expression and phosphorylation were determined by Western blotting. Statistical analyses were performed using paired t test for self-comparison and ANOVA for intergroup comparison followed by Tukey HSD analysis.
Results

␥C-Induced Microvascular Leakage
Administration of recombinant ␥C (10 g/mL) promoted plasma protein extravasation in mesenteric microvessels (Figure 1A and 1B) . Compared to vehicle, ␥C induced a higher level of albumin flux. The leak response occurred rapidly, reached maximum at Ϸ15 minutes, and was reversible on clearance of ␥C. In cannulated microvessels without the presence of platelets or leukocytes, perfusion with ␥C ele- 
␥C-Induced Endothelial Barrier Dysfunction
In microvascular endothelial monolayers, ␥C caused a significant reduction in transcellular electric resistance ( Figure 2 ), indicative of impaired cell-cell adhesive barrier properties. Dose-response studies showed that endothelial TER decreased as a function of ␥C concentrations within a pathophysiological range (5 to 40 g/mL). At lower concentrations, the response was relatively mild and transient, which recovered within 10 to 15 minutes. A high concentration (40 g/mL) caused severe hyperpermeability that persisted for several hours.
Differential Effects of FDPs
We compared the permeability effects of native fibrinogen and its various degradations products, including fragment D (FFD) and the C termini of ␣, ␤, and ␥ chains (␣ E C, ␤C, and ␥C; supplemental Figure II) . Intact fibrinogen at 4 mg/mL (pathophysiological concentration) did not significantly decrease TER or increase microvascular hydraulic conductivity over the same time course as seen with ␥C (supplemental Figure IIA and IIB). Fragment D induced a significant decline in TER; however, it seemed to be less potent than ␥C within the same micromolar range (1 to 2 mol/L FFD versus 1.3 mol/L ␥C; supplemental Figure IIC ). In addition, both ␣ E C and ␤C slightly reduced barrier function but the effects did not reach a statistically significant level (supplemental Figure IID) . Furthermore, a truncated mutant of ␥C lacking the last 12 residues in the C terminus, ␥C399tr, exerted the same hyperpermeability potency as the wild-type ␥C (supplemental Figure IID) , indicating that the extreme C-terminal dodecapeptide sequence is not required for the permeability response.
RhoA Signaling
In microvascular endothelial cells, ␥C induced Rho-GTPase activation and myosin light chain phosphorylation at threonine18/serine19 without changing total protein levels ( Figure  3A and 3B). Concomitantly, actin stress fibers and intercellular gaps were frequently observed. The responses were diminished in the presence of the Rho kinase inhibitor Y27632 ( Figure 3C ). Further, siRNA knockdown of RhoA expression ( Figure 4A ) did not significantly alter the basal permeability but prevented the TER response to ␥C ( Figure  4B ). Likewise, blockage of RhoA signaling with Y27632 inhibited barrier dysfunction in endothelial monolayers (Figure 4C ) and prevented albumin leakage in microvessels caused by ␥C ( Figure 4D ).
␥C Binding Endothelial Cells via Integrin ␣v␤3
Figure 5A demonstrates binding of GFP-␥C to the endothelial cell membrane, an interaction inhibited by preincubation with the ␣v␤3 integrin-blocking antibody. Further, in vivo measurements of mesenteric microcirculation showed that ␥C (10 g/mL) caused a significant increase in albumin transvascular flux; the leak response was greatly attenuated in integrin ␤3-deficient mice ( Figure 5B ).
Discussion
This study reports a direct effect of ␥C on endothelial barrier dysfunction and microvascular leakage. We generated a recombinant protein based on the globular C-domain of human fibrinogen-␥ chain, a component of fibrin degradation products that we previously showed to modulate angiogenesis. 18 Administration of ␥C at pathophysiological concentrations induced a time-and dose-dependent increase in albumin transvascular flux and microvascular hydraulic conductivity in vivo and a decrease in transendothelial electric resistance across microvascular endothelial monolayers. The hyperpermeability effect was coupled with RhoA activation and endothelial cytoskeletal changes characterized by myosin light chain phosphorylation, actin stress fibers and intercellular gap formation. The cellular responses were greatly attenuated during depletion of RhoA expression or inhibition of RhoA function. In microvessels, blockage of RhoA signaling did not significantly alter the basal permeability but prevented ␥C-induced albumin leakage. Further imaging analyses demonstrated binding of ␥C to the endothelial cell membrane through the ␣v␤3 integrin, and that ␥C-induced microvascular leak response was greatly attenuated in ␤3-deficient animals. Taken together, the results suggest that the C-terminal fragment of fibrinogen-␥ interacts with the microvascular endothelium, causing barrier dysfunction via ␣v␤3-mediated RhoA-dependent signaling. Selective blockage of this fragment or targeting its intracellular signaling while maintaining hemostasis The focus of this study is the 30-kDa fragment of fibrinogen-␥ chain, rather than the 340-kDa native protein, with a practical view to characterize the molecular biology of this small proteolytic product as a pathogenic factor or therapeutic target for barrier injury. To the best of our knowledge, these data constitute the first line of evidence for a direct impact of ␥C on microvascular endothelium. In this regard, although elevated circulating fibrinogen has been correlated with increased risk of coronary and peripheral vascular diseases, 4 -7 it remains controversial as to whether it merely represents an acute phase protein elaborated during inflammation, or it is the cause of inflammation. 22 Likewise, although an effect of fibrinogen to promote albumin transendothelial flux has been reported, 9 there is evidence that the intact protein fails to cause pulmonary edema 12 ; rather, it attenuates vascular leakage caused by other inflammatory agents. 10 In this study, we observed a minimal permeability response to native fibrinogen. Furthermore, the fragment D containing cross-linked C termini of ␣, ␤, and ␥ chains was capable of altering endothelial barrier function; however, its effect seemed to be less potent than ␥C. This finding is in line with our previous data that native fibrinogen does not interact with endothelial cells in the same fashion as ␥C and polymerized C-fragments have limited endothelial-binding capability owing to cryptic binding sites. 18 Indeed, recent crystallographic studies reveal a structure featuring multiple binding motifs embedded in pockets that are only reactive under certain conformations. 1, 3, 15 Thus, proteolytic products with exposed endothelial-reactive regions may play a more important role than the intact protein in regulating endotheliumdependent vascular functions. This may explain why Ancrod, a fibrinogenolytic agent, is ineffective in treating myocardial ischemia-reperfusion, as it reduces plasma levels of fibrinogen but simultaneously increases its degradation products that may exacerbate vascular injury. 6 Our data provide a comparative analysis of the permeability effects of different fibrinogen derivates that share the C-terminal homology. Whereas the dimerized C-termini of ␣, ␤, and ␥ chains were capable of causing barrier dysfunction, individual ␣ E C or ␤C chain effected to a much less extent than the D fragment or ␥C, consistent with the hypothesis that the ␥C domain may play a predominant role in the permeability response by providing critical molecular sites for interacting with endothelial cells. Supporting this is recent literature that emphasizes the structural stability and functional importance of the C-terminal sequences of ␥ chain relative to other subunits in coagulation, calcium binding, and interactions with multiple molecules and cells. 7, 13, 15, 23 Unlike ␥C, the crystal structure of ␣C remains elusive and its function has not been well studied because, in part, of its intrinsic instability. 3 Likewise, relatively less information is available regarding the structure-function relationship of ␤C, and there is limited evidence pointing to a direct physiological impact of these segments on vascular permeability.
Specific sequences in fibrinogen-␥ that potentially participate in the interaction with circulating cells and the vascular wall include residues 117 to 133 which bind ICAM-1, 24 377 to 395 which bind CD11b/CD18, 23, 25 and 400 to 411 which bind integrin ␣II␤3. 13, 26 Recent studies reveal the potential of residues 151 to 399 within the C terminus as a binding motif for the endothelial ␣v␤3 integrin in suppression of angiogenesis and tumor growth. 8, 18, 19 Given the signaling role of ␣v␤3 in vascular function and our previous data on its effect in regulating microvascular permeability, 27 we suspect that this integrin serves as a receptor for ␥C to target the endothelial barrier. The current study supports a direct binding interaction between ␥C and ␣v␤3. The in vivo data that ␤3 knockout prevents ␥C-induced microvascular leakage further supports the functional importance of this integrin in mediating the barrier response. The lack of permeability response to ␥C in ␤3-deficient microvessels may result from the phenotypic changes and vascular defects in these mice; however, further studies are required to explain the underlying mechanisms. On the other hand, the ability of ␥C to interact with the endothelial integrin receptor may not depend on its extreme C-terminal dodecapeptide (aa 400-411), as deletion of these residues did not reduce the hyperpermeability potency of ␥C, consistent with our previous finding that truncated ␥C mutants maintain the ability to recognize ␣v␤3. 18 Interestingly, a previous study suggests that fragment D increases bovine pulmonary artery endothelial permeability in the absence of the ␥-chain extreme C terminus. 11 The study varies from ours in that different preparations of fibrinolytic products were tested with different experimental models. Within this context, although a high level of structural homology exits among the C termini of fibrinogen-␣, ␤, and ␥ chains as well as across species (humans and rodents), 28 heterogeneous responses have been observed in endothelial cells of different species or vascular origins. Furthermore, it is possible that other integrins or nonintegrin receptors are involved in the ␥C-endothelium interaction. 29, 30 Although a search for detailed molecular structures is underway, we thought to first establish the intracellular signaling pathway that leads to ␥C-induced hyperpermeability.
We found that activation of RhoA served as a critical step in the transduction of ␥C action. The central role of this Rho-GTPase in modulating endothelial barrier function during inflammation has been recognized. [31] [32] [33] [34] However, whether it mediates hyperpermeability to any particular fibrinogen degradation product remains to be determined. A novel aspect of the current study is that it provides direct evidence for RhoA-dependent hyperpermeability to the C-terminal fragment of fibrinogen-␥. The concomitant changes in endothelial adhesive barrier function and myosin light chain phosphorylation and stress fiber formation were prevented by RhoA depletion or inhibition, indicating the RhoA-stimulated cytoskeleton contraction as a potential cellular process underlying paracellular hyperpermeability. Indeed, cascades of intracellular reactions cross-talk with the Rho-pathway, 35 where activation of RhoA can be triggered by receptor tyrosine kinases or the ␤ integrins 36 -38 and its downstream targets range from signaling molecules, such as protein kinase C and myosin light chain kinase, 39, 40 to barrier structural components, such as actin, myosin, microtubules, and junctions. [31] [32] [33] 41, 42 In addition, the MAPK cascades have been linked to RhoA signaling. A recent study reports the involvement of ERK1/2 in fibrinogen-induced permeability. 9 However, based on our observation that inhibition of ERK1/2 activation did not block ␥C-induced barrier dysfunction (data not shown), it is unlikely that this pathway serves as the major effector in ␥C-RhoA signaling.
Both the transcellular and paracellular pathways have been proposed to explain macromolecule transport across the microvascular endothelium during inflammation 34, 43 ; their relative contribution to vascular leakage varies depending on experimental conditions, inflammatory stimuli, vessel subtypes, and the presence or absence of blood components and immune cells. 44, 45 Taking advantage of the availability of multiple permeability models, we performed a comprehensive analysis of endothelial barrier function under conditions where these confounding factors were dissected. The study was initiated with intravital microscopy that measures plasma protein extravasation in the intact microvasculature indicative of the overall exchange status in the presence of circulating cells. 20 We then measured hydraulic conductivity in single perfused microvessels without platelets and leukocytes, examining the direct effect of ␥C on intact endothelium. 21 This in situ experiment is mechanistically important because the Lp values are reflective of convective transport mainly through the paracellular pathway. 21, 41 After this was a study in endothelial monolayers of microvascular origin for monitoring the dynamics of transcellular electric resistance, an indicator of cell-cell and cell-matrix adhesive barrier properties. Information derived from these experiments does not exclude the participation of circulating components but highlights the direct endothelial effect of ␥C. Moreover, although we recognize the potential involvement of other cellular pathways such as transcytosis, our data emphasize the importance of the paracellular pathway, supported by evidence that RhoA activation causes myosin light chain phosphorylation, actin polymerization, and endothelial cell contraction; these responses are known to mediate paracellular permeability. [31] [32] [33] [34] 41 The rapid, reversible nature of ␥C-induced hyperpermeability is consistent with a dynamic regulation of cell-cell adhesions, rather than permanent cell detachment or apoptosis, which may occur in late stages (8 to 24 hours) or after prolonged (Ͼ12 hours) challenge of ␥C. 11, 18 In summary, we report that the C-terminal fragment of fibrinogen ␥-chain is capable of disrupting the microvascular endothelial barrier leading to fluid and protein leakage. The hyperpermeability response may result from a direct interaction of ␥C with the endothelial ␣v␤3 integrin receptor and is mediated by RhoA-dependent signaling. This finding indicates an intriguing possibility that proteolytic products containing the C-terminal fragments of fibrinogen act as inflammatory mediators causing vascular dysfunction during tissue injury or thrombotic disorder. In addition, ␥C-induced microvascular hyperpermeability may have implications in the pathophysiological regulation of angiogenesis, tumor development, and wound healing. Investigative efforts shall be continued to characterize the biochemical nature and molecular basis of ␥C-endothelium interactions.
